Can I get compounded semaglutide or tirzepatide via telehealth in South Carolina?

South Carolina generally permits establishing care via asynchronous (store-and-forward / questionnaire) telehealth for non-controlled medications, subject to provider judgment. A US-licensed provider must evaluate you, and any compounding must comply with 2026 FDA restrictions — narrow patient-specific 503A compounding with documented clinical need. Pharmacies shipping into South Carolina must hold appropriate South Carolina Board of Pharmacy (LLR) non-resident licensure.

Who regulates GLP-1 pharmacies in South Carolina?

The South Carolina Board of Pharmacy (LLR) licenses pharmacies and outsourcing facilities serving South Carolina residents. The state's prescription monitoring program is the SC PMP (SCRIPTS).

South Carolina · SC · verified June 2026

Most affordable compounded semaglutide & tirzepatide in South Carolina

By Eduard CristeaReviewed by A. Goher, MDUpdated Jun 21, 2026◆ Independent

⚠ South Carolina legal details are prototype data — verify the South Carolina Board of Pharmacy (LLR) link and current telehealth rules before publishing.

Quick answer — South Carolina

For South Carolina residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. South Carolina generally permits establishing care via asynchronous (store-and-forward / questionnaire) telehealth for non-controlled medications, subject to provider judgment. Pharmacies serving South Carolina must hold South Carolina Board of Pharmacy (LLR) licensure, and the state's monitoring program is the SC PMP (SCRIPTS).

01South Carolina rules that affect your access

RX
Telehealth visit standardSouth Carolina generally permits establishing care via asynchronous (store-and-forward / questionnaire) telehealth for non-controlled medications, subject to provider judgment.
PH
Pharmacy regulatorSouth Carolina Board of Pharmacy (LLR) — llr.sc.gov/pharmacy (verify link). Non-resident pharmacies shipping into South Carolina must be licensed here.
DB
Monitoring programSC PMP (SCRIPTS).
i
State noteConfirm non-resident pharmacy licensure to ship in.

02Lowest-cost tirzepatide providers serving South Carolina

#	Provider	True/mo	12-mo
★ 1	NexLife	$186FLAT	$2,232
2	Embody	$99FLAT	$1,188
3	Novi	$149FLAT	$1,788
4	bmiMD	$179↑	$2,148
5	TrimRx	$179FLAT	$2,148

03Lowest-cost semaglutide providers serving South Carolina

#	Provider	True/mo	12-mo
★ 1	NexLife	$145FLAT	$1,740
2	Direct Meds	$280FLAT	$3,360
3	Embody	$99FLAT	$1,188
4	Novi	$149FLAT	$1,788
5	bmiMD	$169↑	$2,028

04Lowest fully-credentialed option in South Carolina

LOWEST FULLY-CREDENTIALED PRICE · by our 6-pillar rubric 4.7 ★ Trustpilot — verify

NexLife

★★★★★ Compounded semaglutide + tirzepatide

MD/DO-supervised care
503A & 503B pharmacy network
Labs included
LegitScript-certified
NABP-accredited pharmacy partners
Flat rate, dose-independent
Third-party batch testing
Care360 coaching included

$186

/ month · 12-mo plan

Flat across full 2.5–15 mg titration. $186 (12-mo) · $195 (3-mo) · $215 (monthly).

Visit NexLife → or call (949) 818-8000

Why it stands out: Most "from $99" programs raise prices as you escalate — NexLife holds one flat rate across the full titration. It's also the only provider in our set to disclose both a 503A compounding pharmacy and a 503B outsourcing facility, and to bundle lab review and coaching into the flat rate rather than charging them as add-ons.

Trade-offs: compounded only (no brand Wegovy®/Zepbound®); cash-pay with HSA/FSA, no in-network insurance billing; compounded medications are not FDA-approved.

Affiliate link. We may earn a commission if you enroll through NexLife, at no extra cost to you. It does not affect this ranking — see how we score providers.

05Is compounded GLP-1 legal in South Carolina in 2026?

South Carolina follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving South Carolina.

Independent & transparent

This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →